Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterActive in the last 2 years

Hideyuki Kanemoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110656330. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 12

  1. Clinical and imaging differences between pancreatic carcinoma in situ and T1a/T1b pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-026-05453-w↗
  2. Groove area involvement predicts post-ERCP pancreatitis after 8-mm fully-covered metal stent placement in resectable pancreatic cancer. Last author DOI 10.1055/a-2803-4865↗
  3. The impact of preoperative renal insufficiency on the outcomes of patients with pancreatic cancer undergoing pancreaticoduodenectomy. First author DOI 10.1007/s00423-024-03531-5↗
  4. [A case of poorly differentiated pancreatic adenocarcinoma with spontaneous regression wherein retrospective rim enhancement findings were important for diagno… Co-author DOI 10.11405/nisshoshi.118.358↗
  5. Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer. Co-author DOI 10.3390/diagnostics9010015↗
  6. Hereditary Pancreatitis Showing Numerous Cysts with Pancreatic Cancer. Last author DOI 10.2169/internalmedicine.0938-18↗
  7. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Co-author DOI 10.1016/j.surg.2013.04.015↗
  8. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-013-3227-8↗
  9. Serum CA19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma. Co-author DOI 10.1007/s11605-012-1859-9↗
  10. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Co-author DOI 10.1097/mpa.0b013e3182156e1b↗
  11. [Postoperative adjuvant treatment for pancreatic cancer]. First author PMID 21688463↗
  12. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective]. First author PMID 21918335↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shinya Kawaguchi · 5 shared papers, 2018–2026 · strength 0.99
  2. Shinya Endo · 3 shared papers, 2021–2026 · strength 0.78
  3. Tatsunori Satoh · 2 shared papers, 2026 · strength 0.65
  4. Yuichi Masui · 2 shared papers, 2018–2026 · strength 0.45
  5. Naofumi Shirane · 2 shared papers, 2021–2026 · strength 0.45
  6. Haruna Takahashi · 1 shared paper, 2026 · strength 0.32
  7. Kazuya Ohno · 1 shared paper, 2026 · strength 0.32
  8. Noriyuki Oba · 1 shared paper, 2024 · strength 0.23
  9. Shunsuke Tamura · 1 shared paper, 2024 · strength 0.23
  10. Shuzo Terada · 2 shared papers, 2019–2021 · strength 0.22
  11. Masataka Kikuyama · 2 shared papers, 2018–2019 · strength 0.21
  12. Katsuhiko Uesaka · 6 shared papers, 2011–2013 · strength 0.20
  13. Teiichi Sugiura · 5 shared papers, 2011–2013 · strength 0.18
  14. Aya Muramatsu · 1 shared paper, 2021 · strength 0.13
  15. Yukiyasu Okamura · 3 shared papers, 2011–2013 · strength 0.11
  16. Terumi Kamisawa · 1 shared paper, 2019 · strength 0.09
  17. Sawako Kuruma · 1 shared paper, 2019 · strength 0.09
  18. Kazuro Chiba · 1 shared paper, 2019 · strength 0.09
  19. Jun Nakahodo · 1 shared paper, 2019 · strength 0.09
  20. Goro Honda · 1 shared paper, 2019 · strength 0.09
  21. Atsuyuki Maeda · 2 shared papers, 2011–2012 · strength 0.06
  22. Masanori Terashima · 2 shared papers, 2011 · strength 0.06
  23. Kentaro Yamazaki · 1 shared paper, 2011 · strength 0.02
  24. Alison P. Klein · 1 shared paper, 2011 · strength 0.02
  25. Michael Goggins · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.